Digital Anticipatory Protocols at Triage to Improve ED Flow.
Implementing Digital Anticipatory Protocols at Triage to Improve Emergency Department Flow: A Before-After Study Protocol
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Thomas Castelain
- Número de teléfono: +41263061392
- Correo electrónico: thomas.castelain@h-fr.ch
Copia de seguridad de contactos de estudio
- Nombre: Youcef Guechi
- Número de teléfono: +41263063142
- Correo electrónico: youcef.guechi@h-fr.ch
Ubicaciones de estudio
-
-
Canton of Fribourg
-
Villars-sur-Glâne, Canton of Fribourg, Suiza, 1752
- Reclutamiento
- Fribourg Cantonal Hospital
-
Contacto:
- Thomas Castelain
- Número de teléfono: +41263061392
- Correo electrónico: thomas.castelain@h-fr.ch
-
Contacto:
- Youcef Guechi
- Correo electrónico: youcef.guechi@h-fr.ch
-
Investigador principal:
- Youcef Guechi, MD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- All patients over 18 years who registered at the admission desk during the study period.
Exclusion Criteria:
- Arrival by emergency medical services (ambulance or helicopter)
- Patient trajectory bypassing the standard nurse-led triage process
- Patient directly referred to another service of the hospital after triage (gynecology, ophthalmology, etc.).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Phase 1 - Pre-intervention
Patients presenting to the emergency department between May 1st and July 31st, 2026.
Patients undergo standard triage assessment performed using the revised Swiss Emergency Triage Scale (SETS).
Disposition decisions are monitored using a digital tag in the electronic health records.
|
|
|
Phase 2 - Post-intervention
Patients presenting to the emergency department between May 1st and July 31st, 2027.
Patients undergo triage with the addition of a new digital anticipatory protocol.
Disposition decisions continue to be monitored using the same digital tag.
|
The intervention consists of adding digital checkboxes to the electronic triage system.
This provides nurses with formalized options for anticipated management based on patient acuity, aiming to encourage and document anticipatory actions while stimulating clinical reasoning.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Total Emergency Department Length of Stay (ED LOS).
Periodo de tiempo: Through completion of the ED visit, up to a maximum of 72 hours.
|
The time interval from the completion of the patient's administrative registration to their physical departure from the ED
|
Through completion of the ED visit, up to a maximum of 72 hours.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Left without being seen (LWBS)
Periodo de tiempo: Through completion of the ED visit, up to a maximum of 72 hours.
|
Proportion of patients who registered at the ED admission desk and left before receiving a medical screening exam or an evaluation by a physician
|
Through completion of the ED visit, up to a maximum of 72 hours.
|
|
30-day mortality
Periodo de tiempo: Up to 30 days post-ED visit
|
Assessed through institutional medical records to evaluate safety
|
Up to 30 days post-ED visit
|
|
Intesive Care Unit (ICU) transfers
Periodo de tiempo: Up to 7 days post-ED visit
|
Proportion of patients transferred to the Intensive Care Unit (ICU) immediately and within 7 days after the ED visit
|
Up to 7 days post-ED visit
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time From Triage Assessment to Disposition Decision
Periodo de tiempo: Through completion of the ED visit, up to a maximum of 72 hours.
|
The time interval, measured in minutes, elapsed from the beginning of the nursing triage assessment to the exact moment a definitive disposition decision (e.g., discharge, admission) is entered by the emergency physician. A disposition decision is operationally defined as the precise moment the attending emergency physician determines that active emergency care is complete. This includes the decision to transfer the patient to a hospital ward (for admissions) or the conclusion of clinical management (for discharges), even if the patient remains in the emergency department awaiting purely logistical arrangements, such as medical transport or family arrival. The measurement tool used to assess and timestamp this outcome is a standardized digital disposition decision tag integrated into the electronic health record. |
Through completion of the ED visit, up to a maximum of 72 hours.
|
|
Time From Treatment Room Placement to Disposition Decision
Periodo de tiempo: Through completion of the ED visit, up to a maximum of 72 hours.
|
The time interval, measured in minutes, elapsed from when the patient is placed in an ED treatment room to the exact moment a definitive disposition decision (e.g., discharge, admission) is entered by the emergency physician. A disposition decision is operationally defined as the precise moment the attending emergency physician determines that active emergency care is complete. This includes the decision to transfer the patient to a hospital ward (for admissions) or the conclusion of clinical management (for discharges), even if the patient remains in the emergency department awaiting purely logistical arrangements, such as medical transport or family arrival. The measurement tool used to assess and timestamp this outcome is a standardized digital disposition decision tag integrated into the electronic health record. |
Through completion of the ED visit, up to a maximum of 72 hours.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Youcef Guechi, MD, Hopital Cantonal Fribourgeois (HFR)
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- Req-2026-00230
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .